Skip to main content
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
3.260
-0.025 (-0.76%)
At close: Mar 9, 2026, 4:00 PM EDT
3.430
+0.170 (5.21%)
After-hours: Mar 9, 2026, 5:36 PM EDT

Oramed Pharmaceuticals Revenue

Oramed Pharmaceuticals had revenue of $2.00M in the twelve months ending September 30, 2025.

Revenue (ttm)
$2.00M
Revenue Growth
n/a
P/S Ratio
64.88
Revenue / Employee
$500,000
Employees
4
Market Cap
129.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M-9.00K-0.33%
Dec 31, 20212.71M9.00K0.33%
Aug 31, 20212.70M-9.00K-0.33%
Dec 31, 2020 Pro Pro Pro
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Gossamer Bio 44.05M
Spero Therapeutics 40.55M
Equillium 4.39M
Cardiff Oncology 593.00K
Artiva Biotherapeutics 251.00K
Inovio Pharmaceuticals 182.34K
Adagene 103.20K
Genelux 8.00K
Revenue Rankings

ORMP News

More News